.jpg)
.png)
All
li{ margin-bottom: 10px; } In June of 2013, the Health Quality Research Committee was tasked by Merck and Company to perform a research project to identify and understand the barriers that exist and prevent patients from reaching their LDL-C goals as it relates to health information... more
"Charles Darwin didn’t say that only the strong survive, he said those who survive are the ones who most accurately perceive their environment and successfully adapt to it." - Leon Megginson In many ways, we are at a crossroads. Emphasis on the focal point of Darwin’s... more
This year, SELA was excited to collaborate with the Foundation of the NLA to provide financial support to Health First Community Health Center to conduct LDL-C, Triglyceride, and A1C screenings in rural and un/underinsured populations in Kentucky. Patients were provided with educational resources... more
Since loss-of-function mutations in proprotein convertase subtilisin-kexin type 9 (PCSK9) were found to be associated with reduction in low-density lipoprotein cholesterol levels (LDL-C) and coronary events1, there has been great anticipation of the development of effective therapeutic agents to... more
American Association of Clinical Endocrinologists While you take advantage of our many informational and supportive services, please take time to gain insight into our organization by browsing through the information provided on this website. We are confident that we offer clinical... more
To download the Summer WordSpin, click here! Guidelines for the crossword: 1. Answers to most questions can be found in this edition. 2. There are no spaces or dashes between multiple word answers. 3. No words are used twice.
Amgen recently announced that the FOURIER trial met its primary and secondary endpoints in evaluating whether evolocumab reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD) without new safety issues. Amgen also announced that... more
Blood Lipid Response to Physical Activity and Exercise Training A prevailing myth among patients and many healthcare providers is the notion that physical exercise “burns” or oxidizes cholesterol or cholesterol-rich particles similar to the utilization of fatty acids and glucose. This doesn’t... more
The NLA has long prided itself on developing timely and relevant scientific statements, which is also a key strategy to help the NLA achieve its mission, “to enhance the practice of lipid management in clinical medicine.” Developing scientific statements is an important responsibility... more